Pharmaceutical giant Takeda is implementing a new round of job cuts in the United States as it prepares for the... Read more
Category: Uncategorized
GSK accelerates development of subcutaneous cancer therapy through tech licensing
Pharmaceutical giant GSK is undertaking a strategic move to optimize the administration of its flagship immunotherapy through a new technological... Read more
Ministry of Health Strengthens Leadership Across Key Departments
In a move to reinforce its organizational structure and enhance governance efficiency, the Ministry of Health has announced a series... Read more
Nationwide recall of 77 cosmetic products over missing documentation
Pharmaceutical authorities have issued a strict enforcement action against 77 cosmetic items distributed by a Hanoi-based firm. The large-scale recall... Read more
Proposed financial mechanism to support juvenile victims
A new legal framework is being developed to establish a compensation and emergency support system for victims under the age... Read more
Novartis secures FDA breakthrough therapy designation for Sjögren’s disease
Recognition from U.S. regulatory authorities On January 19, 2026, the U.S. Food and Drug Administration (FDA) officially granted "Breakthrough Therapy"... Read more
Biotech IPO wave in 2026: Agomab and SpyGlass unveil public listing plans
Signals of a capital market recovery The beginning of 2026 has witnessed signs of a resurgence in the biotech IPO... Read more
AstraZeneca secures full global rights for CAR-T liver cancer therapy
Consolidation of global control On January 19, 2026, AstraZeneca officially reached an agreement to acquire AbelZeta Pharma’s 50% stake in... Read more
Emmecell appoints new CEO to advance commercialization of ophthalmic cell therapies
Executive leadership transition On January 16, 2026, Emmecell, a clinical-stage biotechnology company pioneering magnetic cell delivery (MCD) technology, officially appointed... Read more








